Public offerings often lead to short-term declines in a company's stock price due to the dilution of existing shares. Investors may perceive the offering as a sign that the company is in need of cash, which can be interpreted negatively. Given that Panbela Therapeutics is directly conducting the offering, the news is highly relevant and important to the company's financial situation and investor sentiment.